Richard Bowen
Colorado State University
H-index: 67
North America-United States
Top articles of Richard Bowen
Cellular Injury Repair in the Distal Lung Following Exposure to E-cigarette Vape (EV)
2024/5
Mucosal immunization with dual influenza/COVID-19 single-replication virus vector protects hamsters from SARS-CoV-2 challenge
Vaccine
2024/4/19
LVS ΔcapB-vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice
Mbio
2024/4/10
A stapled lipopeptide platform for preventing and treating highly pathogenic viruses of pandemic potential
Nature Communications
2024/1/4
Biodetection of an odor signature in white-tailed deer associated with infection by chronic wasting disease prions.
bioRxiv
2024
Feral swine as indirect indicators of environmental anthrax contamination and potential mechanical vectors of infectious spores
Pathogens
2023/4/20
Oral Administration of universal bacterium-vectored nucleocapsid-expressing COVID-19 vaccine is efficacious in hamsters
Microbiology Spectrum
2023/4/13
Pathogen reduction of monkeypox virus in plasma and whole blood using riboflavin and UV light
PLoS One
2023/1/20
mRNA vaccines encoding membrane-anchored receptor-binding domains of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
bioRxiv
2023
Richard Bowen
H-Index: 35
Advax-CpG55. 2-adjuvanted monovalent or trivalent SARS-CoV-2 recombinant spike protein vaccine protects hamsters against heterologous infection with Beta or Delta variants
Vaccine
2023/11/22
Richard Bowen
H-Index: 35
Nikolai Petrovsky
H-Index: 38
Compositions comprising inactivated microbes, and methods for use and production thereof
2023/11/16
Production Of Vaccines Comprising Inactivated SARS-COV-2 Viral Particles
2023/11/2
Evaluation of Pathogenesis and Immune Response to Coccidi-oides posadasii Infection in US Feral Swine (Sus scrofa)
2023/7/26
Intranasal single-replication influenza vector induces cross-reactive serum and mucosal antibodies against SARS-CoV-2 variants
Vaccines
2023/6/5
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
EBioMedicine
2023/6/1
Tim Smith
H-Index: 2
Richard Bowen
H-Index: 35
IGSF3 (immunoglobulin superfamily 3) and glycosphingolipids associated with lung cell proliferation during recovery from respiratory SARS-CoV-2 infection
2023/5/23
Richard Bowen
H-Index: 35
Immunoglobulin Superfamily Member 3 Inhibits Epithelial Cell Proliferation and May Delay Lung Repair Following SARS-CoV-2 Infection
2023/5
Disease Progression and Serological Assay Performance in Heritage Breed Pigs following Brucella suis Experimental Challenge as a Model for Naturally Infected …
Pathogens
2023/4/24
Nebulized delivery of a broadly neutralizing SARS-CoV-2 RBD-specific nanobody prevents clinical, virological, and pathological disease in a Syrian hamster model of COVID-19
MAbs
2022/12/31
Optimized ACE2 decoys neutralize antibody-resistant SARS-CoV-2 variants through functional receptor mimicry and treat infection in vivo
Science advances
2022/12/7
